Entera Announces Second Quarter 2026 Financial Results and Business Updates
Entera reported a Q2 net loss of $7.3 million, or $0.14 per share, with R&D expenses increasing to $3.2 million to support Phase 3 preparation activities. The company closed an oversubscribed $275 million private placement led by BVF, which is expected to fully fund the EB613 registrational program and extend its cash runway into 2030.
Key figures
- Guidance
- Phase 3 study initiation planned for late 2026 with topline data anticipated in the second half of 2028; cash runway extended into 2030
- Net loss
- $7.3 million
- Ga expenses
- $1.4 million
- Rd expenses
- $3.2 million
- Cash position
- $11.3 million
- Gross proceeds
- $275.0 million
AI analysis
Red flags1 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.